A rare case of intravascular large T-cell lymphoma with an unusual T helper phenotype

American Journal of Dermatopathology

Volumn 33, Issue 8, 2011, Pages

  Deetz, Carl O ^a   Gilbertson II, Kenneth G ^a   Anadkat, Milan J ^a   Dehner, Louis P ^a   Lu, Dongsi ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

B cell; Intravascular large cell lymphoma; T cell; T helper

Indexed keywords

BRENTUXIMAB VEDOTIN; CARBOPLATIN; CD2 ANTIGEN; CD3 ANTIGEN; CD30 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; GEMCITABINE; GRANZYME B; MONOCLONAL ANTIBODY D2-40; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VIMENTIN; VINCRISTINE;

ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER REGRESSION; CARCINOMA CELL; CASE REPORT; CERVICAL LYMPHADENOPATHY; CYTOTOXIC T LYMPHOCYTE; DERMIS; DIABETES MELLITUS; ENDOTHELIUM CELL; HELPER CELL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAVASCULAR LARGE T CELL LYMPHOMA; LARGE CELL LYMPHOMA; LYMPH NODE BIOPSY; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SKIN BIOPSY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; ENDOTHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; PHENOTYPE; PREDICTIVE VALUE OF TESTS; T-LYMPHOCYTES, HELPER-INDUCER; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; VASCULAR NEOPLASMS;

EID: 82455162351     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e318221bc25     Document Type: Article

References (36)

1. Pfeger L, Tappeiner J. Zur kenntnis der systemisierten endotheliomatose der cuanen blutegefasse. Hautarzt. 1959;10:359-363.
2. Sepp N, Schuler G, Romani N, et al. Intravascular lymphomatosis (angioendotheliomatosis): Evidence for a T-cell origin in two cases. Human Pathol. 1990;21:1051-1058. (Pubitemid 20349229)
3. Sheibani K, Battifora H, Winberg CD, et al. Further evidence that "malignant angioendotheliomatosis" is an angiotropic large-cell lymphoma. N Engl J Med. 1986;614:943-948. (Pubitemid 16129828)
4. Cerroni L, Gatter K, Kerl H. Skin Lymphoma. Oxford, United Kingdom: Blackwell Publishing; 2009.
5. Ferreri AJM, Campo E, Seymour JF, et al. Intravascular lymphoma: Clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the "cutaneous variant." Br J Haematol. 2004;127:173-183. (Pubitemid 39371810)
6. Cerroni L, Massone C, Kutzner H, et al. Intravascular large T-cell or NKcell lymphoma. Am J Surg Pathol. 2008;32:892-898.
7. Takahashi E, Fukatsu T, Eimoto T, et al. Intravascular large T-cell lymphoma: A case report of CD30-positive and ALK-negative anaplastic type with cytotoxic molecule expression. Virchows Arch. 2005;447:1000-1006. (Pubitemid 41719557)
8. Wang L, Li C, Gao T. Cutaneous intravascular anaplastic large cell lymphoma. J Cutan Pathol. 2011;38:221-226.
9. Au WY, Shek WH, Nicholls J, et al. T-cell intravascular lymphomatosis (angiotropic large cell lymphoma): Association with Epstein-Barr virus infection. Histopathology. 1997;31:563-567. (Pubitemid 28008021)
10. Bhawan J,Wolff SM, Ucci AA, et al. Malignant lymphoma and malignant angioendotheliomatosis: One disease. Cancer. 1985;55:570-576. (Pubitemid 15156025)
11. Chen M, Qui B, Kong J, et al. Angiotropic T-cell lymphoma. Chin Med J. 1998;111:762-764.
12. Clark WC, Dohan FC Jr, Moss T, et al. Immunocytochemical evidence of lymphocytic derivation of neoplastic cells in malignant angioendotheliomatosis. J Nerosurg. 1991;74:757-762.
13. Di Giuseppi JA, Nelson WG, Seifter EJ, et al. Intravascular lymphomatosis: A clinicopathologic study of 10 cases and assessment of response to chemotherapy. J Clin Oncol. 1994;12:2573-2579. (Pubitemid 24379641)
14. Ghorbani RP, Shokouh-Amiri H, Gaber LW. Intragraft angiotropic largecell lymphoma of T cell-type in a long-term renal allograft recipient. Mod Pathol. 1996;9:671-676. (Pubitemid 26227570)
15. Glass J, Hochberg FH, Miller DC. Intravascular lymphomatosis: A systemic disease with neurologic manifestations. Cancer. 1993;71: 3156-3164. (Pubitemid 23145554)
16. Kaluza V, Rao DS, Said JW, et al. Primary extranodal nasal-type natural killer/T-cell lymphoma of the brain: A case report. Hum Pathol. 2006;37: 769-772. (Pubitemid 43956545)
17. Ko YH, Han JH, Go JH, et al. Intravascular lymphomatosis: A clinicopathologic study of two cases presenting as interstitial lung disease. Histopathology. 1997;31:555-562. (Pubitemid 28008020)
18. Kuo TT, Chen MJ, Kuo M. Cutaneous intravascular NK-cell lymphoma: A report of a rare variant associated with Epstein-Barr virus. Am J Surg Pathol. 2006;30:1197-1201. (Pubitemid 44299355)
19. Lakhani SR, Hulman G, Hall JM, et al. Intravascular malignant lymphomatosis (angiotropic large cell lymphoma). A case report with evidence for T-cell lineage with polymerase chain reaction analysis. Histopathology. 1994;25:283-286. (Pubitemid 24298442)
20. Lopez-Gil F, Roura M, Umbert I, et al. Malignant proliferative angioendotheliomatosis or angiotropic lymphoma associated with a soft tissue lymphoma. J Am Acad Dermatol. 1992;26:101-104.
21. Malicki DM, Suh YK, Fuller GN, et al. Angiotropic (intravascular) large cell lymphoma of T-cell phenotype presenting as acute appendicitis in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med. 1999;123:335-337. (Pubitemid 29172068)
22. Merchant SH, Viswanatha DS, Zumwalt RE, et al. Epstein-Barr virus associated intravascular large T-cell lymphoma presenting as acute renal failure in a patient with acquired immunodeficiency syndrome. Hum Pathol. 2003;34:950-954. (Pubitemid 37169628)
23. Sangueza O, Hyder DM, Sangueza P. Intravascular lymphomatosis: Report of an unusual case with T cell phenotype occurring in an adolescent male. J Cutan Pathol. 1992;19:226-231.
24. Santucci M, Pimpinelli N, Massi D, et al. Cytotoxic/natural killer cell cutaneous lymphomas. Report of the EORTC Cutaneous Lymphoma Task Force Workshop. Cancer. 2003;97:610-627. (Pubitemid 36125838)
25. Setoyama M, Mizoguchi S, Orikawa T, et al. A case of intravascular malignant lymphomatosis (angiotropic large cell lymphoma) presenting memory T cell phenotype and its expression of adhesion molecules. J Dermatol. 1992;19:263-269.
26. Shimokawa I, Higami Y, Sakai H, et al. Intravascular malignant lymphomatosis: A case of T-cell lymphoma probably associated with human T-cell lymphotropic virus. Hum Pathol. 1991;22:200-202.
27. Song DE, Lee MW, Ryu MH, et al. Intravascular large cell lymphoma of natural killer cell type. J Clin Oncol. 2007;25:1279-1282.
28. Stroup RM, Sheibani K, Moncada A, et al. Angiotropic (intravascular) lymphoma: A clinicopathologic study of seven cases with unique clinical presentations. Cancer. 1990;66:1781-1788. (Pubitemid 20381217)
29. Suh CH, Kim SK, Shin DH, et al. Intravascular lymphomatosis of the T cell type presenting as interstitial lung disease-a case report. J Korean Med Sci. 1997;12:457-460. (Pubitemid 127711368)
30. Sukpanichnant S, Visuthisakchai S. Intravascular lymphomatosis: A study of 20 cases in Thailand and a review of the literature. Clin Lymphoma Myeloma. 2006;6:319-328.
31. Tateyama H, Eimoto T, Tada T, et al. Congenital angiotropic lymphoma (intravascular lymphomatosis) of the T-cell type. Cancer. 1991;67: 2131-2136.
32. Williams G, Foyle A, Greer W, et al. Intravascular T-cell lymphoma with bowel involvement: A case report and literature review. Am J Hematol. 2005;78:207-211. (Pubitemid 40316499)
33. Wu H, Said JW, Ames ED, et al. First reported cases of intravascular large cell lymphoma of the NK cell type. Clinical, histologic, immunophenotypic and molecular features. Am J Clin Pathol. 2005;123:603-611. (Pubitemid 40418556)
34. Nakamura S, Ponzoni M, Campo E. Intravascular large B-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008:252-253.
35. Deetz CO, Hebbler AM, Propp NA, et al. Gamma interferon secretion by human Vgamma2Vdelta2 T cells after stimulation with antibody against the T-cell receptor plus the Toll-like receptor 2 agonist Pam3Cys. Infect Immun. 2006;74:4505-4511. (Pubitemid 44157236)
36. Tikhonov I, Deetz CO, Paca R, et al. Human Vgamma2Vdelta2 T cells contain cytoplasmic RANTES. Int Immunol. 2006;18:1243-1251. (Pubitemid 44349299)